Accordingly, a Kaplan–Meier analysis suggested that leptin overexpression is a positive prognosticator of disease-free survival (DFS) along with disease-specific survival (DSS) in ovarian cancer patients [196]. This evidence concerns the gene LEP and ovarian cancer.